Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.31B | 7.43B | 7.56B | 7.88B | 6.43B | Gross Profit |
3.23B | 3.24B | 3.25B | 3.85B | 3.10B | EBIT |
1.27B | 1.28B | 1.38B | 2.01B | 1.60B | EBITDA |
1.62B | 1.55B | 1.61B | 2.17B | 2.08B | Net Income Common Stockholders |
798.00M | 878.00M | 800.00M | 1.33B | 844.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
674.00M | 1.08B | 1.23B | 1.98B | 3.90B | Total Assets |
4.87B | 5.46B | 5.49B | 6.03B | 11.57B | Total Debt |
4.96B | 5.57B | 6.05B | 6.01B | 9.46B | Net Debt |
4.29B | 4.49B | 4.82B | 4.03B | 5.55B | Total Liabilities |
6.25B | 7.09B | 7.70B | 7.54B | 12.23B | Stockholders Equity |
-1.39B | -1.63B | -2.21B | -1.52B | -662.00M |
Cash Flow | Free Cash Flow | |||
660.00M | 656.00M | 816.00M | 1.22B | 1.81B | Operating Cash Flow |
886.00M | 954.00M | 1.14B | 1.49B | 2.04B | Investing Cash Flow |
-162.00M | -286.00M | -328.00M | -259.00M | -219.00M | Financing Cash Flow |
-1.13B | -815.00M | -1.56B | -3.19B | 610.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $6.36B | 17.30 | 26.89% | 2.86% | 10.01% | 4.13% | |
74 Outperform | $1.49B | 29.82 | 11.97% | ― | 9.09% | 106.50% | |
73 Outperform | $925.20M | 5.18 | 29.74% | ― | 0.17% | 20.26% | |
71 Outperform | $18.65B | 16.28 | 50.39% | ― | 0.79% | -2.70% | |
62 Neutral | $7.19B | 9.35 | -52.83% | 2.37% | -1.63% | -5.94% | |
61 Neutral | $6.98B | 11.36 | 2.88% | 3.90% | 2.65% | -21.74% | |
60 Neutral | $4.90B | 33.40 | -39.97% | ― | 2.18% | -32.87% |
On April 17, 2025, Bath & Body Works hosted an investor tour at its Beauty Park in Columbus, Ohio, showcasing its strategic advantages in agility, innovation, and supply chain management. The event highlighted the company’s integrated development and production capabilities, emphasizing its ability to launch new products swiftly and maintain a strong market position through its vertically integrated supply chain.
Spark’s Take on BBWI Stock
According to Spark, TipRanks’ AI Analyst, BBWI is a Neutral.
Bath & Body Works’ overall stock score reflects significant financial challenges, particularly in leverage and sales decline, which are partly offset by strong cash flow and operational efficiency. Technical indicators show bearish trends, while valuation suggests potential undervaluation. Positive earnings call guidance and corporate actions like share repurchases provide some optimism, but risks remain.
To see Spark’s full report on BBWI stock, click here.
On March 11, 2025, Bath & Body Works’ executive team will participate in the Bank of America Consumer & Retail Conference. The company reaffirms its first quarter 2025 net sales growth of 1% to 3% and earnings per share guidance of $0.36 to $0.43, as well as its full-year fiscal 2025 net sales growth and earnings per share guidance.
On February 27, 2025, Bath & Body Works reported its financial results for the fourth quarter and full-year 2024, showing net sales of $2.8 billion and earnings per diluted share of $2.09 for the fourth quarter, both exceeding guidance. The company also announced a new $500 million share repurchase program and provided 2025 guidance with expected net sales growth of 1% to 3% and earnings per diluted share between $3.25 and $3.60. Despite a decrease in net sales compared to the previous year due to a shifted fiscal calendar, the company demonstrated strong performance driven by product innovation and strategic initiatives.